Comment on 'New-onset type 2 diabetes, elevated HbA1c, anti-diabetic medications, and risk of pancreatic cancer'

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	e11
Journal	British Journal of Cancer
Volume	114
Issue number	11
DOIs	https://doi.org/10.1038/bjc.2016.99 https://doi.org/10.1038/bjc.2016.99
Publication status	Published - 24 May 2016

Research Beacons, Institutes and Platforms

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{f89c1c363851425a875005baf14fbf36,

title = "Comment on 'New-onset type 2 diabetes, elevated HbA1c, anti-diabetic medications, and risk of pancreatic cancer'",

author = "Ellena Badrick and Matthew Sperrin and Renehan, {Andrew G.}",

year = "2016",

month = may,

day = "24",

doi = "10.1038/bjc.2016.99",

language = "English",

volume = "114",

pages = "e11",

journal = "British Journal of Cancer",

issn = "0007-0920",

publisher = "Springer Nature",

number = "11",

}

TY - JOUR

T1 - Comment on 'New-onset type 2 diabetes, elevated HbA1c, anti-diabetic medications, and risk of pancreatic cancer'

AU - Badrick, Ellena

AU - Sperrin, Matthew

AU - Renehan, Andrew G.

PY - 2016/5/24

Y1 - 2016/5/24

U2 - 10.1038/bjc.2016.99

DO - 10.1038/bjc.2016.99

M3 - Letter

C2 - 27219288

SN - 0007-0920

VL - 114

SP - e11

JO - British Journal of Cancer

JF - British Journal of Cancer

IS - 11

ER -